← back to search

Patrick Blaney

University of Minnesota, Twin Cities · US
Area of research
Hematology · Molecular Biology
Research interest
Research interests include Multiple myeloma, Biology, Computational biology, Medicine, Chromothripsis, and Gene.
h-index
citations
316
works
13
NIH funding
primary concept
email

Recent publications

Temporal genomic dynamics shape clinical trajectory in multiple myeloma
Nature Genetics 2025cited by 9position: middledoi
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes
Blood 2025cited by 8position: middledoi
A proinflammatory response and polarized differentiation of stromal elements characterizes the murine myeloma bone marrow niche
Experimental Hematology and Oncology 2025cited by 6position: middledoi
Genomics Define Malignant Transformation in Myeloma Precursor Conditions
Journal of Clinical Oncology 2025cited by 6position: middledoi
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma
Clinical Cancer Research 2024cited by 16position: middledoi
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma
Blood 2024cited by 15position: middledoi
Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 1position: middledoi
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Nature Cancer 2023cited by 51position: middledoi
Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
Blood Cancer Journal 2022cited by 20position: middledoi
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
Nature Communications 2021cited by 51position: middledoi
Chromothripsis as a pathogenic driver of multiple myeloma
Seminars in Cell and Developmental Biology 2021cited by 39position: middledoi
Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
Leukemia 2021cited by 14position: middledoi
Accelerated single cell seeding in relapsed multiple myeloma
Nature Communications 2020cited by 80position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gareth J. Morgan · Amyloidosis Foundation6 papers (2021–2025)Ola Landgren · Miami University5 papers (2021–2025)Francesco Maura · Palmetto General Hospital5 papers (2021–2025)Faith E. Davies · New York University Florence5 papers (2021–2025)Eileen M. Boyle · Curtin University4 papers (2021–2025) · 3 papers (2021–2025)David Kaminetzky · NYU Langone Health3 papers (2021–2025)Louis Williams · Cleveland Clinic Lerner College of Medicine3 papers (2021–2025)Yubao Wang · The University of Texas Southwestern Medical Center3 papers (2021–2025)Kylee Maclachlan · Memorial Sloan Kettering Cancer Center3 papers (2021–2024) · 3 papers (2021–2025)Brian A. Walker · University of Miami3 papers (2021–2025)Benjamin Diamond · University of Miami2 papers (2021–2024)Michael Bauer · University of Arkansas for Medical Sciences2 papers (2021–2022) · 2 papers (2025–2025)Even H. Rustad · Oslo University Hospital2 papers (2021–2021)Bachisio Ziccheddu · University of Miami Health System2 papers (2021–2024)Neha Korde · Weill Cornell Medicine1 papers (2024–2024)Marios Papadimitriou · University of Miami1 papers (2024–2024)Romanos Sklavenitis‐Pistofidis · Broad Institute1 papers (2024–2024)